3SBio Inc. (HKG:1530)
23.00
-0.04 (-0.17%)
Feb 3, 2026, 4:08 PM HKT
3SBio Employees
3SBio had 6,268 employees as of June 30, 2025. The number of employees increased by 691 or 12.39% since the number was reported on December 31, 2024.
Employees
6,268
Change
691
Growth
12.39%
Revenue / Employee
1.59M HKD
Profits / Employee
412.33K HKD
Market Cap
57.55B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 6,268 | 691 | 12.39% | 6,268 | 0 |
| Dec 31, 2024 | 5,577 | 166 | 3.07% | 5,577 | 0 |
| Dec 31, 2023 | 5,411 | 198 | 3.80% | 5,411 | 0 |
| Dec 31, 2022 | 5,213 | -79 | -1.49% | 5,213 | 0 |
| Dec 31, 2021 | 5,292 | -236 | -4.27% | 5,292 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 23,056 |
| Innovent Biologics | 6,190 |
| Genscript Biotech | 5,769 |
| Shanghai Henlius Biotech | 3,537 |
| Akeso | 3,529 |
| RemeGen | 3,070 |
| Shanghai Junshi Biosciences | 2,670 |
| Sichuan Kelun-Biotech Biopharmaceutical | 1,870 |
3SBio News
- 7 weeks ago - 3SBio Sells Shares, Divests Subsidiary To Boost Capital - Benzinga
- 2 months ago - China’s 3SBio seeks US$400 million in Hong Kong to boost drug pipeline - South China Morning Post
- 2 months ago - 3SBio spin-off Mandi banks on hair-loss and weight-loss drugs in Hong Kong IPO - South China Morning Post
- 3 months ago - Innovent's License Deal Fails To Excite investors - Benzinga
- 6 months ago - Pfizer, Chinese biotech firm 3SBio complete licensing deal for cancer drug - South China Morning Post
- 8 months ago - Pfizer's Mega Deal Highlights China's Rising Role In Global Pharma - Benzinga
- 9 months ago - Pfizer Thinks Bigger With 3SBio Deal - Seeking Alpha
- 9 months ago - Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China - Investopedia